Bailitianheng: Plans to raise no more than 3.764 billion yuan, all of which will be used for innovative drug research and development.

Jin10 data reported on May 30th that Baili Tianheng announced that the company plans to issue A-share stocks to specific targets and raise no more than 3.764 billion yuan. After deducting issuance costs, the actual funds raised will be entirely used for innovative drug research and development projects.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)